# clm_A5E3AA28CA83

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 10,883,610,000 United States dollar  
valid_from: 2013-09-30  
valid_to: 2013-12-31  
published: 2013-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_220CB7E7E545  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 10,883,610,000 United States dollar", as of 2013-09-30 (until 2013-12-31). Claim clm_A5E3AA28CA83, https://asof.is/claim/clm_A5E3AA28CA83, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209513000046/0000882095-13-000046-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209513000046/0000882095-13-000046-index.htm (primary, SEC EDGAR 10-Q Q3 FY2013, published 2013-10-31)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 11,092,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_A5E3AA28CA83](/claim/clm_A5E3AA28CA83.md) | [clm_48AE970C35D8](/claim/clm_48AE970C35D8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.